QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the expansion of its cell and gene therapy (CGT) portfolio ...

New solutions support high-precision analytics for process development, batch release, and regulatory compliance.

The Hi-PCR ® Dengue Serotyping Probe PCR Kit 2.0 ... Dengue fever, caused by the Dengue virus (DENV), represents a major vector-borne infectious disease with worldwide implications.

If expression constructs were generated by subcloning, constructs may be PCR-amplified without the vector sequence and injected directly into the gonad.

Technical advances and enhanced automation are taking droplet digital PCR from a specialized research technique to a robust quality-control tool. In 2019, Eriko Uchida, a researcher at the ...

QIAcuity digital PCR kits, assays and protocols for lentivirus-based therapies support quality control in cell and gene therapy manufacturing Expansion underscores the commitment of QIAGEN ...